IP-2018 has been brought out in 4 Volumes incorporating 220 new monographs (Chemical
Monographs (170), Herbal Monographs (15), Blood and Blood related products (10), Vaccines and
Immunosera for Human use monographs (02), Radiopharmaceutical monographs (03), Biotechnology
Derived Therapeutic Products (06), Veterinary monographs (14)), 366 revised monographs and 7
Salient Features of IP-2018
Keeping in view the essential requirement for harmonization of analytical methods with those accepted
internationally, steps have been taken for monitoring drug standards.
General Chemical tests & Thin Layer Chromatography (TLC) for identification of an article
have been almost eliminated and more specific infrared, ultraviolet spectrophotometer and HPLC
tests have been given emphasis. The concept of relying on published infrared spectra as a basis
for identification has been continued.
The use of chromatographic methods has been greatly extended to cope with the need for more
specificity in assays and in particular, in assessing the nature and extent of impurities in
ingredients and products.
Most of the existing Assays and Related Substances Test methods are upgraded by liquid
chromatographic in view to harmonize with other International PharmacopoeiaSource: http://ipc.nic.in
For more detail visit at : http://ipc.nic.in/showfile.asp?lid=851&EncHid